Cargando…

Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice

Engineering of functional tissue, by combining either autologous or allogeneic cells with biomaterials, holds promise for the treatment of various diseases and injuries. Prevascularization of the engineered tissue was shown to enhance and improve graft integration and neovascularization post-implant...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, Luba, Merdler, Uri, Elishaev, Maria, Levenberg, Shulamit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953003/
https://www.ncbi.nlm.nih.gov/pubmed/31757007
http://dx.doi.org/10.3390/cells8121472
_version_ 1783486550817898496
author Perry, Luba
Merdler, Uri
Elishaev, Maria
Levenberg, Shulamit
author_facet Perry, Luba
Merdler, Uri
Elishaev, Maria
Levenberg, Shulamit
author_sort Perry, Luba
collection PubMed
description Engineering of functional tissue, by combining either autologous or allogeneic cells with biomaterials, holds promise for the treatment of various diseases and injuries. Prevascularization of the engineered tissue was shown to enhance and improve graft integration and neovascularization post-implantation in immunocompromised mice. However, the neovascularization and integration processes of transplanted engineered tissues have not been widely studied in immunocompetent models. Here, we fabricated a three-dimensional (3D) vascularized murine muscle construct that was transplanted into immunocompetent and immunocompromised mice. Intravital imaging demonstrated enhanced neovascularization in immunocompetent mice compared to immunocompromised mice, 18 days post-implantation, indicating the advantageous effect of an intact immune system on neovascularization. Moreover, construct prevascularization enhanced neovascularization, integration, and myogenesis in both animal models. These findings demonstrate the superiority of implantation into immunocompetent over immunocompromised mice and, therefore, suggest that using autologous cells might be beneficial compared to allogeneic cells and subsequent immunosuppression. Taken together, these observations have the potential to advance the field of regenerative medicine and tissue engineering, ultimately reducing the need for donor organs and tissues.
format Online
Article
Text
id pubmed-6953003
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69530032020-01-23 Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice Perry, Luba Merdler, Uri Elishaev, Maria Levenberg, Shulamit Cells Article Engineering of functional tissue, by combining either autologous or allogeneic cells with biomaterials, holds promise for the treatment of various diseases and injuries. Prevascularization of the engineered tissue was shown to enhance and improve graft integration and neovascularization post-implantation in immunocompromised mice. However, the neovascularization and integration processes of transplanted engineered tissues have not been widely studied in immunocompetent models. Here, we fabricated a three-dimensional (3D) vascularized murine muscle construct that was transplanted into immunocompetent and immunocompromised mice. Intravital imaging demonstrated enhanced neovascularization in immunocompetent mice compared to immunocompromised mice, 18 days post-implantation, indicating the advantageous effect of an intact immune system on neovascularization. Moreover, construct prevascularization enhanced neovascularization, integration, and myogenesis in both animal models. These findings demonstrate the superiority of implantation into immunocompetent over immunocompromised mice and, therefore, suggest that using autologous cells might be beneficial compared to allogeneic cells and subsequent immunosuppression. Taken together, these observations have the potential to advance the field of regenerative medicine and tissue engineering, ultimately reducing the need for donor organs and tissues. MDPI 2019-11-20 /pmc/articles/PMC6953003/ /pubmed/31757007 http://dx.doi.org/10.3390/cells8121472 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Perry, Luba
Merdler, Uri
Elishaev, Maria
Levenberg, Shulamit
Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
title Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
title_full Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
title_fullStr Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
title_full_unstemmed Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
title_short Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice
title_sort enhanced host neovascularization of prevascularized engineered muscle following transplantation into immunocompetent versus immunocompromised mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953003/
https://www.ncbi.nlm.nih.gov/pubmed/31757007
http://dx.doi.org/10.3390/cells8121472
work_keys_str_mv AT perryluba enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice
AT merdleruri enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice
AT elishaevmaria enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice
AT levenbergshulamit enhancedhostneovascularizationofprevascularizedengineeredmusclefollowingtransplantationintoimmunocompetentversusimmunocompromisedmice